Figure 1
|
Frequency |
Percentage |
|
Diagnosis |
Benign |
17 |
34 |
Premalignant |
21 |
42 |
|
Malignant |
12 |
24 |
|
Total |
50 |
100 |
Table I: Percentage and frequency of the histological diagnosis
NÂș |
Case |
Diagnosis |
Ki67 |
P16 |
P21 |
P53 |
e-cadherin |
Gender |
1 |
7353 |
Benign |
YES |
YES |
YES |
NO |
+++ |
F |
2 |
25654 |
Benign |
NO |
NO |
NO |
NO |
+++ |
F |
3 |
8100 |
Benign |
YES |
NO |
YES |
NO |
+++ |
M |
4 |
101 |
Benign |
YES |
NO |
YES |
NO |
+++ |
M |
5 |
289 |
Benign |
NO |
NO |
NO |
NO |
+++ |
F |
6 |
324 |
Benign |
YES |
NO |
NO |
NO |
+++ |
F |
7 |
351 |
Benign |
NO |
NO |
NO |
NO |
+++ |
F |
8 |
500 |
Benign |
NO |
NO |
NO |
NO |
+++ |
F |
9 |
564 |
Benign |
YES |
YES |
NO |
NO |
+++ |
F |
10 |
808 |
Benign |
YES |
NO |
NO |
NO |
+++ |
M |
11 |
809 |
Benign |
YES |
NO |
NO |
NO |
+++ |
M |
12 |
9732 |
Benign |
YES |
NO |
NO |
NO |
+++ |
F |
13 |
10197 |
Premalign |
YES |
NO |
NO |
NO |
+++ |
F |
14 |
10219 |
Premalign |
YES |
NO |
YES |
NO |
+++ |
F |
15 |
10278 |
Premalign |
YES |
NO |
NO |
NO |
+++ |
F |
16 |
28875 |
Premalign |
YES |
YES |
YES |
YES |
+++ |
F |
17 |
3296 |
Premalign |
YES |
NO |
NO |
NO |
+++ |
F |
18 |
1619 |
Premalign |
YES |
YES |
NO |
NO |
+++ |
M |
19 |
6313 |
Premalign |
YES |
YES |
YES |
YES |
+++ |
F |
20 |
6513 |
Premalign |
YES |
YES |
YES |
NO |
+++ |
M |
21 |
9196 |
Premalign |
NO |
YES |
NO |
NO |
+++ |
M |
22 |
174 |
Premalign |
NO |
NO |
NO |
NO |
+++ |
F |
23 |
2635 |
Premalign |
NO |
NO |
NO |
NO |
+++ |
M |
24 |
2857 |
Premalign |
YES |
NO |
NO |
NO |
+++ |
M |
25 |
6426 |
Premalign |
YES |
NO |
NO |
NO |
+++ |
F |
26 |
9740 |
Premalign |
YES |
NO |
NO |
NO |
+++ |
M |
27 |
23143 |
Premalign |
YES |
YES |
NO |
NO |
+++ |
M |
28 |
23144 |
Premalign |
YES |
NO |
YES |
NO |
+++ |
F |
29 |
1623 |
Premalign |
YES |
NO |
NO |
NO |
+++ |
F |
30 |
4729 |
Premalign |
NO |
NO |
NO |
NO |
+++ |
F |
31 |
9733 |
Premalign |
YES |
NO |
YES |
NO |
+++ |
M |
32 |
23096 |
Premalign |
YES |
YES |
YES |
NO |
+++ |
M |
33 |
23865 |
Premalign |
NO |
NO |
NO |
NO |
+++ |
M |
34 |
4839 |
Malignant |
NO |
NO |
NO |
NO |
+++ |
F |
35 |
8973 |
Malignant |
NO |
YES |
NO |
YES |
+++ |
F |
36 |
5147 |
Malignant |
YES |
YES |
YES |
YES |
+++ |
F |
37 |
7542 |
Malignant |
YES |
NO |
NO |
YES |
+++ |
M |
38 |
8821 |
Malignant |
YES |
NO |
NO |
YES |
+++ |
F |
39 |
1445 |
Malignant |
YES |
NO |
NO |
NO |
+++ |
M |
40 |
2403 |
Malignant |
YES |
YES |
YES |
NO |
+++ |
F |
41 |
4466 |
Malignant |
YES |
YES |
NO |
NO |
+++ |
F |
42 |
7946 |
Malignant |
YES |
NO |
YES |
YES |
+++ |
M |
43 |
23145 |
Malignant |
YES |
NO |
YES |
NO |
+++ |
F |
44 |
2397 |
Malignant |
YES |
YES |
YES |
NO |
+++ |
F |
45 |
5374 |
Malignant |
YES |
YES |
YES |
NO |
+++ |
F |
46 |
6099 |
Malignant |
YES |
NO |
YES |
YES |
+++ |
F |
47 |
6688 |
Malignant |
YES |
YES |
YES |
YES |
+++ |
F |
48 |
6948 |
Malignant |
YES |
NO |
NO |
NO |
+++ |
F |
49 |
8335 |
Malignant |
YES |
NO |
YES |
YES |
+++ |
M |
50 |
8870 |
Malignant |
YES |
NO |
YES |
YES |
+++ |
M |
Table 2: Immunohistochemical and histological results, referring each case. F=female; M=male.
Contingency Table |
|||||
|
Diagnosis |
Total |
|||
Benign |
Malignant |
||||
p16 |
No overexpression |
Count |
24 |
10 |
34 |
p16 % |
70,6% |
29,4% |
100% |
||
Overexpression |
Count |
9 |
7 |
16 |
|
p16 % |
56,3% |
43,8% |
100% |
||
Total |
Count |
33 |
17 |
50 |
|
p16 % |
66% |
34% |
100% |
Table 3: contingency table for protein p16.